Comparing Treatment Options in Ovarian Cancer

James T. Thigpen, MD, discusses the comparison of treatment options in ovarian cancer.

James T. Thigpen, MD, professor of medicine, director of medical oncology, University of Mississippi School of Medicine, discusses the comparison of treatment options in ovarian cancer.

Clinical Pearls

  • In ovarian cancer studies, researchers cannot control what therapies a patient will receive following progression on a study therapy
  • These additional lines of therapy have an impact on survival, making it difficult to make an accurate comparison of therapies
  • Using progression-free survival (PFS) as an endpoint may allow for a clean comparison